Impact of Laparoscopic Adjustable Gastric Banding on Obesity Co-morbidities in the Medium- and Long-Term
- First Online:
- Cite this article as:
- Korenkov, M., Shah, S., Sauerland, S. et al. OBES SURG (2007) 17: 679. doi:10.1007/s11695-007-9118-y
The authors evaluated the impact of laparoscopic adjustable gastric banding (LAGB) on obesity-associated diseases in a series at 3 to 8 years postoperatively, namely diabetes, pulmonary disease, hypertension and knee joint pain.
145 morbidly obese patients underwent LAGB with mean age 38 years and preoperative BMI 48.5 kg/m2 (range 34–7). Changes in BMI and excess BMI loss (EBL) were evaluated.
138 of the 145 patients (95%) were available for full follow-up. At last follow-up, BMI had dropped to 34.0 ±–.4 SD kg/m2, and mean EBL was 61.9 ±–6.1%. Prevalence of obesity-associated disease was significantly reduced: diabetes decreased from 10% to 4%, treatment-requiring pulmonary disease from 15% to 5%, hypertension from 43% to 27%, and knee pain from 47% to 38%.
Following gastric banding, >75% of patients suffering from obesity-related disease had significant decrease or resolution of their co-morbidities.